Literature DB >> 17992535

Correlation of inter-individual variations of amitriptyline metabolism examined in hairs with CYP2C19 and CYP2D6 polymorphisms.

Detlef Thieme1, Burkhard Rolf, Hans Sachs, Dagmar Schmid.   

Abstract

The metabolite ratio of amitriptyline (AT), nortriptyline (NT) and its 10-hydroxy metabolites (E10-OHAT, Z10-OHAT, E10-OHNT and Z10-OHNT) was examined by liquid chromatography-mass spectrometry in hair samples of 23 white infants after long-term administration of AT. High inter-individual variation of the metabolite ratios were observed (e.g. NT/AT = 0.8-8.1, E10-OHNT/Z10-OHNT = 1.6-10.3). The significance of these variations was proven by confirmation of the temporary stability of these ratios within a hair fibre. Moreover, an association of the metabolic phenotype with genetic disposition was observed. The genotypes of CYP2C19 (alleles *2, *3 and *4) and of CYP2D6 (*3, *4, and *6) were examined by conventional polymerase chain reaction genotyping experiments. The relative amount of demethylation (NT/AT) is clearly affected by the number of functional alleles of CYP2C19. The demethylation capacity of CYP2C19 poor metabolizers (3 individuals, compared to 15 extensive metabolizers) was 4.3 times depleted. Moreover, the selectivity of hydroxylation (e.g. E10-OHNT/Z10-OHNT) is significantly correlated with CYP2C19.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992535     DOI: 10.1007/s00414-007-0184-4

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  23 in total

Review 1.  Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

Authors:  Leif Bertilsson; Marja-Liisa Dahl; Per Dalén; Ayman Al-Shurbaji
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

2.  Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.

Authors:  H Yamazaki; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-10-01       Impact factor: 4.013

3.  Characterization of mtDNA SNP typing and mixture ratio assessment with simultaneous real-time PCR quantification of both allelic states.

Authors:  Harald Niederstätter; Michael D Coble; Petra Grubwieser; Thomas J Parsons; Walther Parson
Journal:  Int J Legal Med       Date:  2005-08-09       Impact factor: 2.686

4.  Examination of a long-term clozapine administration by high resolution segmental hair analysis.

Authors:  Detlef Thieme; Hans Sachs
Journal:  Forensic Sci Int       Date:  2006-06-12       Impact factor: 2.395

5.  Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.

Authors:  J A Goldstein; J Blaisdell
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.

Authors:  K Venkatakrishnan; J Schmider; J S Harmatz; B L Ehrenberg; L L von Moltke; J A Graf; P Mertzanis; K E Corbett; M C Rodriguez; R I Shader; D J Greenblatt
Journal:  J Clin Pharmacol       Date:  2001-10       Impact factor: 3.126

Review 7.  Some aspects of genetic polymorphism in the biotransformation of antidepressants.

Authors:  Kim Brøsen
Journal:  Therapie       Date:  2004 Jan-Feb       Impact factor: 2.070

8.  Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers.

Authors:  Werner Steimer; Konstanze Zöpf; Silvia von Amelunxen; Herbert Pfeiffer; Julia Bachofer; Johannes Popp; Barbara Messner; Werner Kissling; Stefan Leucht
Journal:  Clin Chem       Date:  2004-06-17       Impact factor: 8.327

9.  A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects.

Authors:  Sebastian Raimundo; Claudia Toscano; Kathrin Klein; Joachim Fischer; Ernst-Ulrich Griese; Michel Eichelbaum; Matthias Schwab; Ulrich M Zanger
Journal:  Clin Pharmacol Ther       Date:  2004-08       Impact factor: 6.875

10.  Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.

Authors:  Katja Grasmäder; Petra Louise Verwohlt; Marcella Rietschel; Aleksandra Dragicevic; Matthias Müller; Christoph Hiemke; Nikolaus Freymann; Astrid Zobel; Wolfgang Maier; Marie Luise Rao
Journal:  Eur J Clin Pharmacol       Date:  2004-05-28       Impact factor: 2.953

View more
  8 in total

Review 1.  Alternative Sampling Strategies for Cytochrome P450 Phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

Review 2.  Clinical association between pharmacogenomics and adverse drug reactions.

Authors:  Zhi-Wei Zhou; Xiao-Wu Chen; Kevin B Sneed; Yin-Xue Yang; Xueji Zhang; Zhi-Xu He; Kevin Chow; Tianxin Yang; Wei Duan; Shu-Feng Zhou
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

Review 3.  Psychotropic drug-drug interactions involving P-glycoprotein.

Authors:  Yumiko Akamine; Norio Yasui-Furukori; Ichiro Ieiri; Tsukasa Uno
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

4.  Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

5.  Assignment of unknown persons to their geographical origin by determination of stable isotopes in hair samples.

Authors:  Elisabeth Mützel Rauch; Christine Lehn; Oliver Peschel; Stefan Hölzl; Andreas Rossmann
Journal:  Int J Legal Med       Date:  2008-09-24       Impact factor: 2.686

6.  Cocaine and opiate concentrations in hair from subjects in a heroin maintenance program in comparison to a methadone substituted group.

Authors:  Frank Musshoff; Katrin Lachenmeier; Dirk Lichtermann; Burkhard Madea
Journal:  Int J Legal Med       Date:  2008-07-26       Impact factor: 2.686

Review 7.  Clinical applications of CYP genotyping in psychiatry.

Authors:  Edoardo Spina; Jose de Leon
Journal:  J Neural Transm (Vienna)       Date:  2014-09-09       Impact factor: 3.575

8.  Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.

Authors:  Karla Claudio-Campos; Adaixa Padrón; Gabriel Jerkins; Jaison Nainaparampil; Robyn Nelson; Anna Martin; Kristin Wiisanen; D Max Smith; Yulia Strekalova; Michael Marsiske; Emily J Cicali; Larisa H Cavallari; Carol A Mathews
Journal:  Clin Transl Sci       Date:  2020-11-09       Impact factor: 4.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.